AU2021901259A0 - Immunogenic vaccines and uses thereof - Google Patents

Immunogenic vaccines and uses thereof

Info

Publication number
AU2021901259A0
AU2021901259A0 AU2021901259A AU2021901259A AU2021901259A0 AU 2021901259 A0 AU2021901259 A0 AU 2021901259A0 AU 2021901259 A AU2021901259 A AU 2021901259A AU 2021901259 A AU2021901259 A AU 2021901259A AU 2021901259 A0 AU2021901259 A0 AU 2021901259A0
Authority
AU
Australia
Prior art keywords
immunogenic vaccines
vaccines
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021901259A
Inventor
Ryan O'Handley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Adelaide
Original Assignee
University of Adelaide
Filing date
Publication date
Application filed by University of Adelaide filed Critical University of Adelaide
Publication of AU2021901259A0 publication Critical patent/AU2021901259A0/en
Pending legal-status Critical Current

Links

AU2021901259A 2021-04-29 Immunogenic vaccines and uses thereof Pending AU2021901259A0 (en)

Publications (1)

Publication Number Publication Date
AU2021901259A0 true AU2021901259A0 (en) 2021-05-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP4112648A4 (en) Anti-sars-cov-2 infection protein and vaccine
EP3947475A4 (en) Coronavirus vaccine compositions, methods, and uses thereof
EP3717511A4 (en) Zika vaccines and immunogenic compositions, and methods of using the same
EP4034548A4 (en) Coronavirus vaccines and uses thereof
EP3600396A4 (en) Nucleic acid vaccine composition comprising a lipid formulation, and method of increasing the potency of nucleic acid vaccines
SG11202003796XA (en) Zika vaccines and immunogenic compositions, and methods of using the same
EP3900741A4 (en) Samrna vaccine and preparation method therefor
EP3943089A4 (en) Freeze-dried formulation, preparation method and application thereof
EP3983085A4 (en) Novel adjuvant for animal and human vaccines
EP3723784A4 (en) Modified clostridial neurotoxins as vaccines and conjugate vaccine platforms
EP3856895A4 (en) Bihaptenized autologous vaccines and uses thereof
EP3762022A4 (en) Human papillomavirus vaccines and uses of the same
EP3703745A4 (en) Immunogenic conjugates and methods of use thereof
EP3749356A4 (en) A vaccine composition and uses thereof
IL308201A (en) Multivalent vaccine compositions and uses thereof
EP3838916A4 (en) Vaccine used for preventing toxoplasma gondii infection and preparation method therefor
AU2021901259A0 (en) Immunogenic vaccines and uses thereof
EP3923981A4 (en) Vaccine adjuvants and formulations
AU2019902524A0 (en) Immunogenic Vaccines and uses thereof
EP3897691A4 (en) Il-10-containing vaccines and uses thereof
AU2021902407A0 (en) Vaccine construct and uses thereof
EP3784250A4 (en) Methods of enhancing immunogenicity of poorly immunogenic antigen-specific vaccines using oral yeast beta-glucans
AU2022902819A0 (en) Vaccine construct and uses thereof
AU2021902988A0 (en) Immunogenic compositions and uses thereof
AU2019903349A0 (en) An alphavirus vaccine and uses thereof